Wall Street Zen Downgrades Edap Tms (NASDAQ:EDAP) to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $2.00.

Edap Tms Price Performance

Shares of NASDAQ:EDAP opened at $3.73 on Friday. The company has a 50 day moving average of $4.21 and a 200 day moving average of $3.16. The company has a current ratio of 1.54, a quick ratio of 1.19 and a debt-to-equity ratio of 0.84. The stock has a market cap of $139.46 million, a P/E ratio of -4.84 and a beta of -0.19. Edap Tms has a 12 month low of $1.21 and a 12 month high of $5.05.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, March 25th. The medical equipment provider reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.09). Edap Tms had a negative return on equity of 100.07% and a negative net margin of 41.24%.The firm had revenue of $22.22 million during the quarter, compared to analysts’ expectations of $21.28 million. As a group, sell-side analysts forecast that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

A number of institutional investors and hedge funds have recently bought and sold shares of EDAP. Flax Pond Capital LLC bought a new stake in Edap Tms during the fourth quarter valued at approximately $2,623,000. Leonteq Securities AG purchased a new position in Edap Tms in the 4th quarter worth approximately $313,000. Rock Springs Capital Management LP increased its holdings in shares of Edap Tms by 1.3% in the 4th quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock worth $4,233,000 after buying an additional 16,500 shares during the last quarter. Kovack Advisors Inc. bought a new position in shares of Edap Tms in the 4th quarter worth $53,000. Finally, Financial Planning Navigators CORP bought a new position in shares of Edap Tms in the 4th quarter worth $33,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.